Literature DB >> 15188505

Expression of gonadotropin-releasing hormone receptor and effect of gonadotropin-releasing hormone analogue on proliferation of cultured gastric smooth muscle cells of rats.

Lei Chen1, Hong-Xuan He, Xu-De Sun, Jing Zhao, Li-Hong Liu, Wei-Quan Huang, Rong-Qing Zhang.   

Abstract

AIM: To investigate the expression of gonadotropin-releasing hormone (GnRH) receptor and the effects of GnRH analog (alarelin) on proliferation of cultured gastric smooth muscle cells (GSMC) of rats.
METHODS: Immunohistochemical ABC methods and in situ hybridization methods were used to dectect protein and mRNA expression of GnRH receptor in GSMC, respectively. Techniques of cell culture, OD value of MTT test, measure of (3)H-TdR incorporation, average fluorescent values of proliferating cell nuclear antigen (PCNA) and flow cytometric DNA analysis were used in the experiment.
RESULTS: The cultured GSMC of rats showed immunoreactivity for GnRH receptor; positive staining was located in cytoplasm. GnRH receptor mRNA hybridized signals were also detected in cytoplasm. When alarelin (10(-9), 10(-7), 10(-5) mol/L) was administered into the medium and incubated for 24 h, OD value of MTT, (3)H-TdR incorporation and average fluorescent values of PCNA all decreased significantly as compared with the control group (P<0.05). The maximum inhibitory effect on cell proliferation was achieved a concentration of 10(-5) mol/L and it acted in a dose-dependent manner. Flow cytometric DNA analysis revealed that alarelin could significantly enhance ratio of G(1) phase and decrease ratio of S phase of GSMC of rats (P<0.05). The maximum inhibitory effect on ratio of S phase was at the concentration of 10(-5) mol/L and also acted in a dose-dependent manner.
CONCLUSION: Our data suggest that GnRH receptor can be expressed by GSMC of rats. GnRH analogue can directly inhibit proliferation and DNA synthesis of rat GSMC through GnRH receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188505      PMCID: PMC4572268          DOI: 10.3748/wjg.v10.i12.1780

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

Review 1.  The smooth muscle cell in culture.

Authors:  J Chamley-Campbell; G R Campbell; R Ross
Journal:  Physiol Rev       Date:  1979-01       Impact factor: 37.312

2.  Immunohistochemical and in situ hybridization studies of gonadotropin releasing hormone (GnRH) and its receptor in rat digestive tract.

Authors:  W Huang; B Yao; L Sun; R Pu; L Wang; R Zhang
Journal:  Life Sci       Date:  2001-03-02       Impact factor: 5.037

3.  A study on the localization and distribution of GnRH and its receptor in rat submaxillary glands by immunohistochemical, in situ hybridization and RT-PCR.

Authors:  Bing Yao; WeiQuan Huang; YuFeng Huang; YingXia Chui; YongMei Wang; HongJun Li; RuoLei Pu; Lei Wan; RongQin Zhang
Journal:  Life Sci       Date:  2003-05-09       Impact factor: 5.037

4.  Regulation of gonadotropin-releasing hormone and its receptor gene expression by 17beta-estradiol in cultured human granulosa-luteal cells.

Authors:  P S Nathwani; S K Kang; K W Cheng; K C Choi; P C Leung
Journal:  Endocrinology       Date:  2000-05       Impact factor: 4.736

5.  Actin and tropomyosin variants in smooth muscles. Dependence on tissue type.

Authors:  V Fatigati; R A Murphy
Journal:  J Biol Chem       Date:  1984-12-10       Impact factor: 5.157

6.  Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer: a putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2.

Authors:  Alon Chen; Ella Kaganovsky; Shai Rahimipour; Nurit Ben-Aroya; Eli Okon; Yitzhak Koch
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

7.  PCNA immunopositivity index as a substitute to 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes.

Authors:  P Galand; G Del Bino; M Morret; P Capel; C Degraef; D Fokan; W Feremans
Journal:  Leukemia       Date:  1995-06       Impact factor: 11.528

8.  [Hormone therapy, chemotherapy and immunotherapy in breast carcinoma. The best strategy for your patient].

Authors:  H G Sayer; K Höffken
Journal:  MMW Fortschr Med       Date:  2003-06-12

9.  Isolation and characterization of cDNAs encoding the rat pituitary gonadotropin-releasing hormone receptor.

Authors:  U B Kaiser; D Zhao; G R Cardona; W W Chin
Journal:  Biochem Biophys Res Commun       Date:  1992-12-30       Impact factor: 3.575

10.  Adenocarcinoma cells are targeted by the new GnRH-PE66 chimeric toxin through specific gonadotropin-releasing hormone binding sites.

Authors:  A Nechushtan; S Yarkoni; I Marianovsky; H Lorberboum-Galski
Journal:  J Biol Chem       Date:  1997-04-25       Impact factor: 5.486

View more
  5 in total

1.  GnRH analogue attenuated apoptosis of rat hippocampal neuron after ischemia-reperfusion injury.

Authors:  Chenyu Chu; Bainan Xu; Weiquan Huang
Journal:  J Mol Histol       Date:  2010-10-15       Impact factor: 2.611

2.  The lower expression of gonadotropin-releasing hormone receptor associated with poor prognosis in gastric cancer.

Authors:  Mingzhu Lu; Jing Zhu; Yang Ling; Wenping Shi; Changsong Zhang; Haorong Wu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  Antibodies against gonadotropin-releasing hormone (GnRH) in patients with diabetes mellitus is associated with lower body weight and autonomic neuropathy.

Authors:  Kerstin Berntorp; Anders Frid; Ragnar Alm; Gunilla Nordin Fredrikson; Klas Sjöberg; Bodil Ohlsson
Journal:  BMC Res Notes       Date:  2013-08-17

4.  Autoantibodies and gastrointestinal symptoms in infertile women in relation to in vitro fertilization.

Authors:  Oskar Hammar; Bodil Roth; Mariette Bengtsson; Thomas Mandl; Bodil Ohlsson
Journal:  BMC Pregnancy Childbirth       Date:  2013-11-05       Impact factor: 3.007

5.  Long‑term follow‑up of buserelin‑induced enteric neuropathy in rats.

Authors:  Anette Jönsson; Elin Sand; Eva Ekblad; Bodil Ohlsson
Journal:  Mol Med Rep       Date:  2016-03-03       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.